AssayIndex

AX-2024-004529

ARA-290 · 10 mg declared · Shenzhen Hybio Pharmaceutical Co., Ltd. · lot HYB-2403-B7301

MARGINALVERIFIED
Report ID
AX-2024-004529
Compound
ARA-290
Compound class
Tissue-repair and immunomodulatory peptides
Supplier
HYB — Shenzhen Hybio Pharmaceutical Co., Ltd.
Batch / lot
HYB-2403-B7301
Declared label claim
10mg
Laboratory
Janoshik Analytical
Assay date
21 Jul 2024
Submitted
01 Aug 2024
Quarter
2024-Q3
Submitter
v.iyer
Sample provenance
Buyer-sourced
Section 1

Results

Measured against the index acceptance specification for the tissue-repair and immunomodulatory peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

ParameterMethodResultUnitIndex spec
PurityRP-HPLC, 30 min gradient, 214 nm99.36% area≥ 98.0PASS
Total impuritiesRP-HPLC, sum of reported peaks0.64% area≤ 2.0PASS
Largest single impurityRP-HPLC — des-Gln truncate (−128 Da)0.38% area≤ 1.00PASS
Identity — theoretical monoisotopic masscalculated from molecular formula1189.6096DaNOT TESTED
Identity — observed monoisotopic massLC-MS, high resolution (ESI-TOF/QTOF)1189.6146DaNOT TESTED
Mass accuracyobserved vs theoretical+4.2ppm± 15PASS
Total peptide contentby difference from the gravimetric mass balance86.70%w/wNOT TESTED
Target-compound contenttotal peptide content × purity86.15%w/wNOT TESTED
Gross fill (as weighed)five-place balance, under nitrogen10.41mg10 mg declaredNOT TESTED
Recovered target peptidegross fill × target content8.968mg10 mg claimNOT TESTED
Recovery against label claimrecovered ÷ claim89.7%90.0 – 110.0FAIL
Water contentKarl Fischer, coulometric, duplicate7.81%≤ 10.0PASS
Counter-ion (acetate)anion-exchange ion chromatography4.80%≤ 12.0PASS
Residual solvent + inorganic residueestimated — see /methods/residual-solvents-q3c/0.69%NOT TESTED
Endotoxinnot ordered on this submissionnot determined≤ 5.0NOT TESTED
Sterilitynot ordered on this submissionnot determinedno growthNOT TESTED
Appearancevisual, diffuse light, black and white backgroundOff-white lyophilised cake, intactwhite to off-white intact cakePASS
Reconstitution clarityreconstituted per submitter procedureClear, colourless, no visible particulatesclear, no visible particulatesPASS
pH (reconstituted, 1 mg/mL)potentiometric, two-point calibration6.212.5 – 8.0PASS
Retention time (observed)RP-HPLC, 30 min gradient8.65min8.72 ± 0.25 (normalised)PASS
Peak asymmetry (10 % height)Ph. Eur. 2.2.460.860.80 – 1.50PASS
Plate count, main peakN = 5.54 (t/w½)²54,314≥ 20,000PASS
Resolution to nearest impurityvs [D-Ser]-diastereomer0.79no index criterionREPORTED
Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

032626524978613048 ARA-2908.65 min · 99.36 % 8.35 same trace · ×100 vertical expansion, baseline-corrected · main peak off-scale reporting threshold 0.05 % area 05101520253035 Retention time (min) Response (mAU)
Figure 1. RP-HPLC trace, 30 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 54,314, and skew follows the reported asymmetry factor of 0.86. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.38 % impurity against a 99.36 % main peak is a line two pixels tall; the main peak runs off-scale there by design.
#PeakRTArea (µV·s)% areaΔ mass (Da)
1ARA-290 — main peak8.654,829,20499.36
2des-Gln truncate (−128 Da)8.3518,4690.38-128.059
3acetyl adduct (+42 Da)9.056,3180.13+42.011
4[D-Ser]-diastereomer8.533,4020.070.000
5deamidated (+1 Da)8.432,9160.06+0.984
Closure check — purity + Σ impurities 100.00CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 1189.6096 Da, computed from C50H83N15O18. All ppm figures on this site are against monoisotopic values — see why that matters.

025507510027545062580097511501325 [M+1H]1+1190.62[M+2H]2+595.81 m/z Relative abundance (%)
Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 1189.6146 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.
ChargeTheoretical m/zObserved m/zΔ m/zRel. abundance (%)
3+397.5438397.54550.00178.5
2+595.8121595.81460.002553.9
1+1190.61691190.62190.0050100.0
Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

ComponentDetermination%w/w of cake
WaterKarl Fischer7.81
Counter-ion (acetate)ion chromatography4.80
Residual solvent + inorganic residueestimated0.69
Total peptide contentby difference86.70
Total100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

FigureSupplier COAThis reportIndex note
Purity (% area)99.7099.36divergence +0.36 pp vs batch median
Total impurities (% area)0.300.64
Largest single impurity (% area)0.180.38
Water (%)not stated7.81
Counter-ion (%)5.04.80
Peptide content (%w/w)90.986.70
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance
Buyer-sourced
Evidentiary weight
Strongest available evidence in this index.
Chain of custody
Retail purchase → third-party forwarder (26 d) → laboratory (courier, cold pack, 7 d) → assay.
Assay date
21 Jul 2024
Submitted to the index
01 Aug 2024
Laboratory
Janoshik Analytical, Ostrava, Czechia
Method basis
30 min gradient · high-resolution MS
Verification status
VERIFIED
Section 6

Annotations 3

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

c18_2p6
Column chemistry flatters or punishes a figure like this. A core-shell column at this gradient resolves the close-eluting family that a fully porous 5 µm bed merges, so 99.36 % here is a harder number than the same figure from a coarser column.
lambda_214
Detection wavelength does not affect a mass determination but it does affect the purity figure sitting next to it. Both are stated on this record, which is the point.
coa_reader
The certificate that arrives with a retail order is the certificate an ordinary buyer gets. Assessing it is assessing the real documentation practice rather than the sample-request one.
Section 7

Related records

Same batch — lot HYB-2403-B7301 n=8

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004522HYB-2403-B7301Janoshik2024-Q399.267.8799.9Buyer-sourced0PASS
AX-2024-004523HYB-2403-B7301Kestrel2024-Q399.667.43Buyer-sourced0PASS
AX-2024-004524HYB-2403-B7301Janoshik2024-Q399.337.74Buyer-sourced0PASS
AX-2024-004525HYB-2403-B7301Medutest2024-Q399.217.4394.6Buyer-sourced0PASS
AX-2024-004526HYB-2403-B7301Nordanalyt2024-Q399.317.6598.1Buyer-sourced0PASS
AX-2024-004527HYB-2403-B7301PeptideMeter2024-Q399.347.49103.7Buyer-sourced0PASS
AX-2024-004528HYB-2403-B7301Medutest2024-Q399.937.3594.8Buyer-sourced0PASS
Other recent ARA-290 records in the index.
ReportSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041767ASYASY-{CAT}-1521Janoshik2026-Q399.664.42103.7Buyer-sourced0PASS
AX-2026-043222SGNSGN-2605-X9069PeptideMeter2026-Q298.327.36Buyer-sourced0PASS
AX-2026-041907SinoPepSNP-2605-G4075Janoshik2026-Q299.205.75Buyer-sourced0PASS
AX-2026-043227SGNSGN-2605-X9069PeptideMeter2026-Q298.387.2195.6Buyer-sourced0PASS
AX-2026-041862GSPGSP-2605-K3362Janoshik2026-Q299.343.32Buyer-sourced0PASS
AX-2026-041906SinoPepSNP-2605-G4075Medutest2026-Q298.945.28Buyer-sourced0PASS
AX-2026-042346HomopeptideHOMO-2601-T3123PeptideMeter2026-Q299.703.47Buyer-sourced0PASS
AX-2026-043229SGNSGN-2605-X9069Janoshik2026-Q298.217.43Buyer-sourced0PASS
Other recent HYB records in the index.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042083MOTS-cHYB-2606-D7858Medutest2026-Q399.932.02Buyer-sourced0PASS
AX-2026-042090MOTS-cHYB-2606-D7858Janoshik2026-Q399.572.36Buyer-sourced1FAIL
AX-2026-042084MOTS-cHYB-2606-D7858Janoshik2026-Q399.282.79107.3Buyer-sourced0PASS
AX-2026-042087MOTS-cHYB-2606-D7858Janoshik2026-Q399.543.05Buyer-sourced0PASS
AX-2026-042085MOTS-cHYB-2606-D7858Janoshik2026-Q399.512.31Buyer-sourced0PASS
AX-2026-042088MOTS-cHYB-2606-D7858PeptideMeter2026-Q399.222.21Buyer-sourced0PASS
AX-2026-042086MOTS-cHYB-2606-D7858Janoshik2026-Q399.933.02Buyer-sourced1MARGINAL
AX-2026-042091CJC-1295 with DACHYB-2608-E7391Janoshik2026-Q399.385.53Buyer-sourced0PASS